Huntington's disease

被引:1273
作者
Walker, Francis O. [1 ]
机构
[1] Wake Forest Univ, Dept Neurol, Winston Salem, NC 27157 USA
关键词
D O I
10.1016/S0140-6736(07)60111-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Huntington's disease is an autosomal-dominant, progressive neurodegenerative disorder with a distinct phenotype, including chorea and dystonia, incoordination, cognitive decline, and behavioural difficulties. Typically, onset of symptoms is in middle-age after affected individuals have had children, but the disorder can manifest at any time between infancy and senescence. The mutant protein in Huntington's disease-huntingtin-results from an expanded CAG repeat leading to a polyglutamine strand of variable length at the N-terminus. Evidence suggests that this tail confers a toxic gain of function. The precise pathophysiological mechanisms of Huntington's disease are poorly understood, but research in transgenic animal models of the disorder is providing insight into causative factors and potential treatments.
引用
收藏
页码:218 / 228
页数:11
相关论文
共 151 条
[1]   A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease [J].
Almqvist, EW ;
Bloch, M ;
Brinkman, R ;
Craufurd, D ;
Hayden, MR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1293-1304
[2]   High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia [J].
Almqvist, EW ;
Elterman, DS ;
MacLeod, PM ;
Hayden, MR .
CLINICAL GENETICS, 2001, 60 (03) :198-205
[3]   Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease [J].
Almqvist, EW ;
Brinkman, RR ;
Wiggins, S ;
Hayden, MR .
CLINICAL GENETICS, 2003, 64 (04) :300-309
[4]   STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT [J].
AMBROSE, CM ;
DUYAO, MP ;
BARNES, G ;
BATES, GP ;
LIN, CS ;
SRINIDHI, J ;
BAXENDALE, S ;
HUMMERICH, H ;
LEHRACH, H ;
ALTHERR, M ;
WASMUTH, J ;
BUCKLER, A ;
CHURCH, D ;
HOUSMAN, D ;
BERKS, M ;
MICKLEM, G ;
DURBIN, R ;
DODGE, A ;
READ, A ;
GUSELLA, J ;
MACDONALD, ME .
SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) :27-38
[5]   Different phenotypic expression in monozygotic twins with Huntington disease [J].
Anca, MH ;
Gazit, E ;
Loewenthal, R ;
Ostrovsky, O ;
Frydman, M ;
Giladi, N .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 124A (01) :89-91
[6]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403
[7]  
[Anonymous], 1994, Neurology, V44, P1533
[8]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[9]   Onset and rate of striatal atrophy in preclinical Huntington disease [J].
Aylward, EH ;
Sparks, BF ;
Field, KM ;
Yallapragada, V ;
Shpritz, BD ;
Rosenblatt, A ;
Brandt, J ;
Gourley, LM ;
Liang, K ;
Zhou, H ;
Margolis, RL ;
Ross, CA .
NEUROLOGY, 2004, 63 (01) :66-72
[10]   p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease [J].
Bae, BI ;
Xu, H ;
Igarashi, S ;
Fujimuro, M ;
Agrawal, N ;
Taya, Y ;
Hayward, SD ;
Moran, TH ;
Montell, C ;
Ross, CA ;
Snyder, SH ;
Sawa, A .
NEURON, 2005, 47 (01) :29-41